Synchron COMMAND pivotal trial two-year follow-up results published
入组10 例严重不良事件0 例随访24 个月
Summary
Data showed no device-related serious adverse events across participants, with functional usage metrics improving further from the early feasibility stage.
Why it matters
两年期安全性数据是血管介入路线走向关键性审批的核心支撑证据。
Sources · 2
NEJM 2026-07-29
公司公告 2026-07-29